← Back to Search

Behavioral Activation (BA) for Opioid Use Disorder

N/A
Waitlist Available
Led By Julia Felton, PhD.
Research Sponsored by Henry Ford Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at study completion; up to 24 weeks
Awards & highlights

Summary

This trial will help to support and train peer recovery coaches to help those with opioid use disorder to stay on their medications and improve their lives.

Eligible Conditions
  • Opioid Use Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at study completion; up to 24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at study completion; up to 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Intervention Feasibility: percentage of patients who agree to participate in the intervention
MOUD Retention Rate
Secondary outcome measures
Intervention Acceptability: percentage of patients enrolled who attend ≥75% sessions
Intervention Fidelity: percentage of intervention components delivered as intended

Side effects data

From 2016 Phase 3 trial • 221 Patients • NCT01299766
5%
Death NOS
4%
Knee replacement
4%
Stroke
2%
Heart attack
2%
bypass surgery
2%
Pacemaker implanted
2%
COPD
2%
GI symptoms
1%
Breast cancer
1%
infection
1%
hypoglycemia
1%
Edema
1%
Fracture
1%
Broken shoulder
1%
Valve replacement
1%
Asthma Attack
1%
Prostate cancer
1%
colon cancer
1%
Blood clot
1%
pneumonia
1%
Hernia repair
1%
Seziure
1%
CHF
1%
aneurysm
1%
Depression
100%
80%
60%
40%
20%
0%
Study treatment Arm
Behavior Activation
Supportive Therapy (ST)

Trial Design

1Treatment groups
Experimental Treatment
Group I: Peer-delivered Behavioral ActivationExperimental Treatment1 Intervention
Adults 18 years or older on MOUD or referred to MOUD will receive Behavioral Activation (BA) an evidence-based intervention (EBI) by trained Peer Recovery Coaches (PRC)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Behavioral Activation (BA)
2014
Completed Phase 3
~350

Find a Location

Who is running the clinical trial?

University of Maryland, College ParkOTHER
157 Previous Clinical Trials
46,212 Total Patients Enrolled
Henry Ford Health SystemLead Sponsor
305 Previous Clinical Trials
2,107,940 Total Patients Enrolled
Julia Felton, PhD.Principal InvestigatorHenry Ford Health System
~11 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top